Blastocystis sp.: A Hidden Player in Gut Health and Disease
Progress In Microbes & Molecular Biology · 11.09.2025 · 8 (1)
DOI: 10.36877/pmmb.a0000471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Progress In Microbes & Molecular Biology, online erschienen am 11.09.2025. Verfasst von Muhammad Mirza Halimi und 12 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Blastocystis sp. (Blastocystis) is a prevalent and diverse gastrointestinal parasite, found in up to 60% of humans and animals worldwide, with particularly high rates in immunocompromised individuals and those in close contact with animals. Its extensive genetic diversity presents a major challenge to diagnostic and treatment standardization, making subtype characterization essential for identifying transmission pathways and assessing infection risks. The clinical significance of Blastocystis is increasingly evident, as it is implicated in a range of gastrointestinal conditions, including irritable bowel syndrome, inflammatory bowel disease, and chronic diarrhea. Its interactions with the host’s immune system and gut microbiome add layers of complexity, shaping the parasite’s impact on health and disease in unpredictable ways. This review examines the multifaceted role of Blastocystis in human health, exploring its association with gastrointestinal disorders, cancer, and dysbiosis, while also evaluating current treatment options and emerging therapeutic strategies. A deeper understanding of these interactions could unlock more effective, targeted interventions for managing Blastocystis infections and the conditions they may influence. Graphical abstract. Clinical significance and management of Blastocystis infection: Blastocystis is associated with cancer, inflammatory bowel disease, and gut microbiota dysbiosis. Current challenges include drug resistance and adverse effects of medications. Standard treatments involve antibiotics and antimicrobials, while alternative approaches such as probiotics, fecal microbiota transplantation, and nanotechnology-assisted drug delivery are being explored.
Zitieren
APA
Halimi, M. M., Wu, Y. S., Lee, M. F., Kumarasamy, V., Kalita, T., Guad, R. M., Saikia, T., Rajendran, K., Tan, R. W. H., Fuloria, N. K., Fuloria, S., Sekar, M., & Subramaniyan, V. (2025). Blastocystis sp.: A Hidden Player in Gut Health and Disease. Progress In Microbes & Molecular Biology, 8(1). https://doi.org/10.36877/pmmb.a0000471
Vancouver
Halimi MM, Wu YS, Lee MF, Kumarasamy V, Kalita T, Guad RM, et al. Blastocystis sp.: A Hidden Player in Gut Health and Disease. Progress In Microbes & Molecular Biology. 2025;8(1). doi:10.36877/pmmb.a0000471
BibTeX
@article{Halimi2025,
author = {Halimi, Muhammad Mirza and Wu, Yuan Seng and Lee, Michelle Felicia and Kumarasamy, Vinoth and Kalita, Tutumoni and Guad, Rhanye Mac and Saikia, Trideep and Rajendran, Kavitha and Tan, Reno Wei Hng and Fuloria, Neeraj Kumar and Fuloria, Shivkanya and Sekar, Mahendran and Subramaniyan, Vetriselvan},
title = {Blastocystis sp.: A Hidden Player in Gut Health and Disease},
journal = {Progress In Microbes & Molecular Biology},
year = {2025},
volume = {8},
number = {1},
doi = {10.36877/pmmb.a0000471}
}
EUVIMED